Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 28

    J B Chemicals Gujarat unit gets EIR from USFDA

    J B Chemicals Gujarat unit gets EIR from USFDA

    Medical Dialogues Bureau12 Feb 2020 1:03 PM IST
    The company has received EIR from the United States Food and Drug Administration (USFDA) for its newly set up and commissioned solid oral dosage forms...
    Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions

    Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions

    Medical Dialogues Bureau12 Feb 2020 12:51 PM IST
    Fluocinonide cream USP, 0.1 per cent, approved by USFDA is indicated to treat a variety of skin conditions such as psoriasis, eczema, dermatitis,...
    Sanofi asks US court to halt diabetes drug patent fight with Mylan

    Sanofi asks US court to halt diabetes drug patent fight with Mylan

    Medical Dialogues Bureau12 Feb 2020 10:30 AM IST
    In a stay application filed on Friday, Sanofi said a recent U.S. Court of Appeals for the Federal Circuit decision upholding the invalidation of two...
    NPPA fixes price of 21 formulations including diabetes drugs, others; Details

    NPPA fixes price of 21 formulations including diabetes drugs, others; Details

    Farhat Nasim11 Feb 2020 12:17 PM IST
    New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
    Cipla arm inks pact for anti-psychotic drug Quetiapine

    Cipla arm inks pact for anti-psychotic drug Quetiapine

    Farhat Nasim11 Feb 2020 12:15 PM IST
    New Delhi: Cipla Medpro South Africa (Pty) Ltd, a wholly-owned subsidiary of Cipla Ltd, India, has recently concluded an exclusive agreement securing...
    Cadila Healthcare Ahmedabad facility gets EIR from USFDA

    Cadila Healthcare Ahmedabad facility gets EIR from USFDA

    Medical Dialogues Bureau11 Feb 2020 12:09 PM IST
    The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying...
    Zealand Pharma to acquire insulin pump maker Valeritas for USD 23 million

    Zealand Pharma to acquire insulin pump maker Valeritas for USD 23 million

    Medical Dialogues Bureau11 Feb 2020 11:30 AM IST
    The agreement with Zealand Pharma, which was reached following a robust and extensive marketing process, provides total cash consideration of $23...
    Roche Alzheimers disease drug fails to meet primary goal

    Roche Alzheimers disease drug fails to meet primary goal

    Medical Dialogues Bureau11 Feb 2020 11:30 AM IST
    Basel: Roche, recently announced that the gantenerumab arm of Phase II/III DIAN-TU-001 study did not meet its primary endpoint in people who have an...
    Coronavirus in China cause of concern for Indian Pharma Sector

    Coronavirus in China cause of concern for Indian Pharma Sector

    Farhat Nasim10 Feb 2020 8:03 PM IST
    New Delhi: Indian pharma firms are closely monitoring the outbreak of coronavirus in China as it could impact the supply of active pharmaceutical...
    Cipla acquires 4 nutrition products from Wanbury for Rs 89 crore

    Cipla acquires 4 nutrition products from Wanbury for Rs 89 crore

    Farhat Nasim10 Feb 2020 11:58 AM IST
    New Delhi: Homegrown pharma firm Cipla on Saturday announced the acquisition of nutrition products portfolio from Wanbury Ltd. The company has...
    Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark

    Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark

    Farhat Nasim9 Feb 2020 11:30 AM IST
    New Delhi: In a major setback to drug giant Sun Pharmaceuticals Ltd.'s arm, Sun Pharma Laboratories Ltd., the Delhi high court has recently dismissed...
    FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government

    FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government

    Farhat Nasim9 Feb 2020 11:00 AM IST
    The foreign direct investment (FDI) equity inflow in the drugs and pharmaceutical sector stood at Rs 1,842 crore in FY 2018-19, Minister of State...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok